Therapeutics

Top Story

Panelists choose both branded, compounded agents for cataract surgery patients

Panelists choose both branded, compounded agents for cataract surgery patients
Primary Care Optometry News, March 2019
Meeting News

Glaucoma expert endorses ‘interventional glaucoma’ treatment

March 12, 2019
NEW ORLEANS – It is time to change glaucoma treatment paradigm, Ike K. Ahmed, MD, said here at SECO. The opportunity is now for disruption and innovation in the…
Meeting News

New drugs, delivery methods in the pipeline for ocular surface, retina, glaucoma

March 8, 2019
NEW ORLEANS – A multitude of treatments options in development for the ocular surface, retina and glaucoma have the potential to greatly improve patient outcomes…
Meeting News

Payment issues may restrict access to new glaucoma treatments

March 6, 2019
NEW ORLEANS – A panel here at the Ophthalmic Innovation Summit, held during SECO, recognized the dramatic advances made in the field of glaucoma technology and…
More Headlines »
CME COPE

Ocular Surface Diseases, Disorders, and Dysfunctions®, Volume 4, Number 2

This activity is supported by an educational grant from Shire.

Ocular surface disease (OSD) is a group of disorders commonly seen in ophthalmic practice, but it is challenging to…
More »
Video
Meeting News

VIDEO: Multiple microbypass stents control IOP better

June 28, 2018
More »
Video
Meeting News Coverage

VIDEO: Drugs, devices bring ‘new era’ of glaucoma care

March 1, 2018
More »